The three vaccines available in the U.S. are safe and effective, but not ideal. Now, work is underway to create more convenient and potent vaccines, including a tablet and nasal spray.
A medical team in New York City says it has performed the first complete surgical transplant of a trachea. These kinds of transplants are one of the last big transplant challenges.
This week’s Medical Minute, discusses cystic fibrosis research into how nutrition, body composition and exercise play in patients’ health across an increasing lifespan. One major goal is to better pinpoint who will develop CF-related diabetes.
The possibility that vaccines meant to prevent the disease may also be a treatment for long COVID — when symptoms linger for months — has sparked optimism among patients and scientists.
This week’s Medical Minute, discusses a manmade molecule called “givinostat” that coaxes stem cells, which have the potential to become any cell type, to become “muscle progenitor cells”, which are useful for recovery from injuries, and the loss of muscle mass that comes with aging.
Same building. Same procedure. Same doctor. But there was an extra "facility fee" because the location changed slightly. A shot that used to cost her about $30 went up to more than $300.
There's no link between COVID-19 vaccines and death. But a new NPR analysis finds stories implying a connection have gone viral this year at a dramatic rate.
Getting the COVID-19 vaccine into most Americans' arms will involve much more than a good supply and logistics. Values such as equity, deep listening, and informed choice are crucial, too.
Ahead of congressional testimony from the heads of Facebook, Twitter and Google, a new NPR analysis finds that articles linking COVID-19 vaccines to death are driving misinformation online.
This week’s Medical Minute, discusses a compound called “EnnA”, which is isolated from a fungus growing on the roots of a flowering plant in Morocco. It is showing signs of being a powerful new weapon in the battle against aggressive, triple negative breast cancer.
Surveys show that support for COVID-19 vaccines is rising among Black and Latinx populations, now that tens of millions of Americans have safely received the shots.
"Its benefits continue to be far greater than its risks," said Dr. Sabine Straus of the agency's risk committee. It found no increase in the overall risk of blood clots with the vaccine.
Researchers have quantified the price paid for fast-spreading COVID-19 infections. Patients who might have survived otherwise perished in crowded ICUs.